Redeye's view of Genovis Q2 report is balanced, sales were largely in line but profitability was softer than we had estimated. We expect making modest adjustments to near-term forecasts on account of the report.
ANNONS
Redeye's view of Genovis Q2 report is balanced, sales were largely in line but profitability was softer than we had estimated. We expect making modest adjustments to near-term forecasts on account of the report.
